Does the media refer more to STAA or MMSI?

In the previous week, Merit Medical Systems had 12 more articles in the media than STAAR Surgical. MarketBeat recorded 20 mentions for Merit Medical Systems and 8 mentions for STAAR Surgical. Merit Medical Systems' average media sentiment score of 1.26 beat STAAR Surgical's score of 0.85 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 10 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ICUI or STAA?

In the previous week, ICU Medical had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 10 mentions for ICU Medical and 8 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat ICU Medical's score of 0.67 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer STAA or HAE?

In the previous week, STAAR Surgical had 1 more articles in the media than Haemonetics. MarketBeat recorded 8 mentions for STAAR Surgical and 7 mentions for Haemonetics. STAAR Surgical's average media sentiment score of 0.85 beat Haemonetics' score of 0.84 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer XRAY or STAA?

In the previous week, DENTSPLY SIRONA had 5 more articles in the media than STAAR Surgical. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 8 mentions for STAAR Surgical. DENTSPLY SIRONA's average media sentiment score of 0.88 beat STAAR Surgical's score of 0.85 indicating that DENTSPLY SIRONA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 6 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is STAA or NEOG more profitable?

STAAR Surgical has a net margin of -7.24% compared to Neogen's net margin of -69.93%. STAAR Surgical's return on equity of 3.31% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets STAAR Surgical -7.24% 3.31% 2.55% Neogen -69.93% 2.35% 1.46%

Does the media refer more to STAA or NEOG?

In the previous week, Neogen had 16 more articles in the media than STAAR Surgical. MarketBeat recorded 24 mentions for Neogen and 8 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat Neogen's score of 0.79 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neogen 7 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

STAAR Surgical (STAA) Competitors

$24.22 +0.35 (+1.47%)

Closing price 07/30/2026 04:00 PM Eastern

Extended Trading

$24.21 -0.01 (-0.04%)

As of 04:00 AM Eastern

Compare

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

Should you buy STAAR Surgical stock or one of its competitors? MarketBeat compares STAAR Surgical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with STAAR Surgical include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), and Neogen (NEOG). These companies are all part of the "health care supplies" industry.

How does STAAR Surgical compare to Merit Medical Systems?

STAAR Surgical (NASDAQ:STAA) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

STAAR Surgical has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Merit Medical Systems had 12 more articles in the media than STAAR Surgical. MarketBeat recorded 20 mentions for Merit Medical Systems and 8 mentions for STAAR Surgical. Merit Medical Systems' average media sentiment score of 1.26 beat STAAR Surgical's score of 0.85 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	10 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems has a net margin of 9.03% compared to STAAR Surgical's net margin of -7.24%. Merit Medical Systems' return on equity of 13.54% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Merit Medical Systems	9.03%	13.54%	7.94%

STAAR Surgical currently has a consensus price target of $26.94, indicating a potential upside of 11.25%. Merit Medical Systems has a consensus price target of $91.78, indicating a potential upside of 10.11%. Given STAAR Surgical's higher possible upside, equities analysts plainly believe STAAR Surgical is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.60

Merit Medical Systems has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$290.38M	4.15	-$80.45M	-$0.43	N/A
Merit Medical Systems	$1.52B	3.28	$128.49M	$2.31	36.08

Summary

Merit Medical Systems beats STAAR Surgical on 12 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

In the previous week, ICU Medical had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 10 mentions for ICU Medical and 8 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat ICU Medical's score of 0.67 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ICU Medical has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.89	$730K	$1.85	91.02
STAAR Surgical	$290.38M	4.15	-$80.45M	-$0.43	N/A

ICU Medical has a net margin of 2.15% compared to STAAR Surgical's net margin of -7.24%. ICU Medical's return on equity of 7.50% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	2.15%	7.50%	3.91%
STAAR Surgical	-7.24%	3.31%	2.55%

ICU Medical has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market.

ICU Medical presently has a consensus price target of $172.00, indicating a potential upside of 2.15%. STAAR Surgical has a consensus price target of $26.94, indicating a potential upside of 11.25%. Given STAAR Surgical's higher probable upside, analysts plainly believe STAAR Surgical is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

ICU Medical beats STAAR Surgical on 11 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to Haemonetics?

STAAR Surgical (NASDAQ:STAA) and Haemonetics (NYSE:HAE) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

STAAR Surgical has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, Haemonetics has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

Haemonetics has higher revenue and earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$290.38M	4.15	-$80.45M	-$0.43	N/A
Haemonetics	$1.33B	2.89	$97.31M	$2.02	41.95

In the previous week, STAAR Surgical had 1 more articles in the media than Haemonetics. MarketBeat recorded 8 mentions for STAAR Surgical and 7 mentions for Haemonetics. STAAR Surgical's average media sentiment score of 0.85 beat Haemonetics' score of 0.84 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

STAAR Surgical currently has a consensus target price of $26.94, indicating a potential upside of 11.25%. Haemonetics has a consensus target price of $78.89, indicating a potential downside of 6.90%. Given STAAR Surgical's higher possible upside, equities analysts plainly believe STAAR Surgical is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Haemonetics	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.82

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 2.1% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Haemonetics has a net margin of 7.29% compared to STAAR Surgical's net margin of -7.24%. Haemonetics' return on equity of 27.30% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Haemonetics	7.29%	27.30%	9.59%

Summary

Haemonetics beats STAAR Surgical on 11 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

In the previous week, DENTSPLY SIRONA had 5 more articles in the media than STAAR Surgical. MarketBeat recorded 13 mentions for DENTSPLY SIRONA and 8 mentions for STAAR Surgical. DENTSPLY SIRONA's average media sentiment score of 0.88 beat STAAR Surgical's score of 0.85 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	6 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

STAAR Surgical has a net margin of -7.24% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
STAAR Surgical	-7.24%	3.31%	2.55%

STAAR Surgical has lower revenue, but higher earnings than DENTSPLY SIRONA. STAAR Surgical is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.75	-$598M	-$3.15	N/A
STAAR Surgical	$290.38M	4.15	-$80.45M	-$0.43	N/A

DENTSPLY SIRONA currently has a consensus price target of $13.46, suggesting a potential downside of 2.03%. STAAR Surgical has a consensus price target of $26.94, suggesting a potential upside of 11.25%. Given STAAR Surgical's higher possible upside, analysts clearly believe STAAR Surgical is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

DENTSPLY SIRONA has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 39.9% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

STAAR Surgical beats DENTSPLY SIRONA on 8 of the 14 factors compared between the two stocks.

How does STAAR Surgical compare to Neogen?

STAAR Surgical (NASDAQ:STAA) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

STAAR Surgical currently has a consensus price target of $26.94, indicating a potential upside of 11.25%. Neogen has a consensus price target of $10.67, indicating a potential downside of 7.49%. Given STAAR Surgical's higher probable upside, research analysts clearly believe STAAR Surgical is more favorable than Neogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Neogen had 16 more articles in the media than STAAR Surgical. MarketBeat recorded 24 mentions for Neogen and 8 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.85 beat Neogen's score of 0.79 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neogen	7 Very Positive mention(s)	1 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 96.7% of Neogen shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 0.6% of Neogen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

STAAR Surgical has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market. Comparatively, Neogen has a beta of 1.8, meaning that its share price is 80% more volatile than the broader market.

STAAR Surgical has a net margin of -7.24% compared to Neogen's net margin of -69.93%. STAAR Surgical's return on equity of 3.31% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Neogen	-69.93%	2.35%	1.46%

STAAR Surgical has higher earnings, but lower revenue than Neogen. STAAR Surgical is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$290.38M	4.15	-$80.45M	-$0.43	N/A
Neogen	$870.56M	2.88	-$1.09B	-$2.80	N/A

Summary

STAAR Surgical beats Neogen on 10 of the 16 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STAA vs. The Competition

Export

Metric	STAAR Surgical	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.19B	$17.35B	$7.04B	$12.02B
Dividend Yield	N/A	1.27%	2.65%	10.11%
P/E Ratio	-56.32	19.60	27.69	23.57
Price / Sales	4.15	2.28	488.19	77.65
Price / Cash	N/A	14.28	51.74	58.30
Price / Book	3.50	3.34	10.04	5.85
Net Income	-$80.45M	$534.24M	$3.60B	$336.53M
7 Day Performance	3.59%	3.08%	0.66%	0.35%
1 Month Performance	-15.58%	5.14%	-3.29%	-4.99%
1 Year Performance	35.16%	7.68%	24.47%	17.95%

STAAR Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAA STAAR Surgical	3.043 of 5 stars	$24.22 +1.5%	$26.94 +11.2%	+33.8%	$1.19B	$290.38M	N/A	1,211	Analyst Forecast
MMSI Merit Medical Systems	2.6614 of 5 stars	$76.10 +2.4%	$92.80 +21.9%	+0.5%	$4.43B	$1.52B	32.94	7,500	Trending News Earnings Report
ICUI ICU Medical	2.2407 of 5 stars	$161.46 +2.6%	$172.00 +6.5%	+34.2%	$3.93B	$2.23B	87.28	13,000	Upcoming Earnings Analyst Downgrade
HAE Haemonetics	1.9553 of 5 stars	$80.07 +1.6%	$78.89 -1.5%	+11.5%	$3.58B	$1.33B	39.64	3,009	News Coverage Upcoming Earnings Analyst Forecast
XRAY DENTSPLY SIRONA	3.1751 of 5 stars	$13.02 +0.7%	$13.42 +3.0%	-11.2%	$2.59B	$3.68B	N/A	14,000	News Coverage Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STAA) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Summary

How does STAAR Surgical compare to ICU Medical?

Summary

How does STAAR Surgical compare to Haemonetics?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Summary

How does STAAR Surgical compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STAAR Surgical (STAA) Competitors

STAA vs. MMSI, ICUI, HAE, XRAY, and NEOG

How does STAAR Surgical compare to Merit Medical Systems?

Which has more volatility & risk, STAA or MMSI?

Do institutionals & insiders believe in STAA or MMSI?

Does the media refer more to STAA or MMSI?

Is STAA or MMSI more profitable?

Do analysts recommend STAA or MMSI?

Which has higher valuation and earnings, STAA or MMSI?

Summary

How does STAAR Surgical compare to ICU Medical?

Does the media prefer ICUI or STAA?

Which has stronger valuation & earnings, ICUI or STAA?

Is ICUI or STAA more profitable?

Which has more risk & volatility, ICUI or STAA?

Do analysts prefer ICUI or STAA?

Do institutionals & insiders believe in ICUI or STAA?

Summary

How does STAAR Surgical compare to Haemonetics?

Which has more volatility and risk, STAA or HAE?

Which has stronger earnings & valuation, STAA or HAE?

Does the media prefer STAA or HAE?

Do analysts recommend STAA or HAE?

Do institutionals and insiders believe in STAA or HAE?

Is STAA or HAE more profitable?

Summary

How does STAAR Surgical compare to DENTSPLY SIRONA?

Does the media prefer XRAY or STAA?

Is XRAY or STAA more profitable?

Which has preferable valuation & earnings, XRAY or STAA?

Do analysts recommend XRAY or STAA?

Which has more volatility and risk, XRAY or STAA?

Do institutionals and insiders hold more shares of XRAY or STAA?

Summary

How does STAAR Surgical compare to Neogen?

Do analysts recommend STAA or NEOG?

Does the media refer more to STAA or NEOG?

Do insiders & institutionals have more ownership in STAA or NEOG?

Which has more risk and volatility, STAA or NEOG?

Is STAA or NEOG more profitable?

Which has preferable earnings and valuation, STAA or NEOG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools